1naresh2naresh<pre>Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => FreeToRead
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

    [003a0dbf-ec0c-4dd0-99e4-5817f866495c] => Array
        (
            [runtime-id] => 003a0dbf-ec0c-4dd0-99e4-5817f866495c
            [type] => toll-free-key
            [service-id] => ajnr-ac.highwire.org
            [access-type] => FreeToRead
            [privilege] => Array
                (
                    [7cd28aed-46d7-4bb7-8835-881123082801] => Array
                        (
                            [runtime-id] => 7cd28aed-46d7-4bb7-8835-881123082801
                            [type] => toll-free-key
                        )

                )

            [credentials] => Array
                (
                    [method] => toll-free-key
                    [value] => tf_ipsecsha;65ed480f6b87a9dcbf9315b9814af4de94a3b17c
                )

        )

)
1naresh2naresh<pre>Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

    [8ecc5d5a-6b95-44da-bcb0-26e62eb4fa01] => Array
        (
            [runtime-id] => 8ecc5d5a-6b95-44da-bcb0-26e62eb4fa01
            [type] => toll-free-key
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [b1fc755d-84fb-4df9-8b2c-150bb8aa451f] => Array
                        (
                            [runtime-id] => b1fc755d-84fb-4df9-8b2c-150bb8aa451f
                            [type] => toll-free-key
                        )

                )

            [credentials] => Array
                (
                    [method] => toll-free-key
                    [value] => tf_ipsecsha;65ed480f6b87a9dcbf9315b9814af4de94a3b17c
                )

        )

)
Reply:
======

* E.M. Genden

The American Thyroid Association guidelines for the management of patients with thyroid nodules1 outlines the role of sonography and fine-needle aspiration for the evaluation of thyroid nodules. Our work and the work of others2(#ref-3)–4 suggest that fluorodeoxyglucose–positron-emission tomography (FDG-PET) positivity is associated with a significant risk of malignancy, not unlike the cytologic reading of “indeterminate cytology,” which, according to the task force (R9, recommendation B), states that a “lobectomy or total thyroidectomy should be considered.”1 We support the work of the American Thyroid Association and believe that FDG-PET positivity simply represents an adjunct to sonography and cytology for the risk assessment of a patient with a thyroid nodule. We do not advocate thyroidectomy for patients with benign cytology and retract any implication of such; however, we do inform patients of the data on FDG-PET positivity—after all, the false-negative rate for fine-needle aspiration of thyroid nodules is higher than the false-positive rate. The American Thyroid Association recommends that a lobectomy or total thyroidectomy be considered for indeterminate cytology, which is associated with a 5%–10% risk of malignancy. Do we feel comfortable withholding surgical intervention when FDG-PET positivity is associated with a 25%–50% risk of malignancy?

## References

1.  1. Cooper DS, Doherty GM, Haugen BR, et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2006;16:109–42 
    
    [CrossRef](http://www.ajnr.org/lookup/external-ref?access_num=10.1089/thy.2006.16.109&link_type=DOI) 
    
    [PubMed](http://www.ajnr.org/lookup/external-ref?access_num=16420177&link_type=MED&atom=%2Fajnr%2F31%2F2%2FE31.atom) 
    
    [Web of Science](http://www.ajnr.org/lookup/external-ref?access_num=000236256100003&link_type=ISI) 

2.  2. Choi JY, Lee KS, Kim HJ, et al. Focal thyroid lesions incidentally identified by integrated 18F-FDG PET/CT: clinical significance and improved characterization. J Nucl Med 2006;47:609–15 
    
    [Abstract/FREE Full Text](http://www.ajnr.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6Njoiam51bWVkIjtzOjU6InJlc2lkIjtzOjg6IjQ3LzQvNjA5IjtzOjQ6ImF0b20iO3M6MTk6Ii9ham5yLzMxLzIvRTMxLmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==) 

3.  3. Kang KW, Kim SK, Kang HS, et al. Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for metastasis evaluation and cancer screening in healthy subjects. J Clin Endocrinol Metab 2003;88:4100–04 
    
    [CrossRef](http://www.ajnr.org/lookup/external-ref?access_num=10.1210/jc.2003-030465&link_type=DOI) 
    
    [PubMed](http://www.ajnr.org/lookup/external-ref?access_num=12970270&link_type=MED&atom=%2Fajnr%2F31%2F2%2FE31.atom) 
    
    [Web of Science](http://www.ajnr.org/lookup/external-ref?access_num=000185258700012&link_type=ISI) 

4.  4. Chen YK, Ding HJ, Chen KT, et al. Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for cancer screening in healthy subjects. Anticancer Res 2005;25:1421–6 
    
    [Abstract/FREE Full Text](http://www.ajnr.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MTA6ImFudGljYW5yZXMiO3M6NToicmVzaWQiO3M6MTA6IjI1LzJCLzE0MjEiO3M6NDoiYXRvbSI7czoxOToiL2FqbnIvMzEvMi9FMzEuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9) 

*   Copyright © American Society of Neuroradiology